ArticleJournal of translational medicine2023

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.

Domenico Mallardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.